83 FR 55739 - Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium
DEPARTMENT OF JUSTICE
Antitrust Division Federal Register Volume 83, Issue 216 (November 7, 2018)
Antitrust Division
Federal Register Volume 83, Issue 216 (November 7, 2018)
| Page Range | 55739-55739 | |
| FR Document | 2018-24335 |
[Federal Register Volume 83, Number 216 (Wednesday, November 7, 2018)] [Notices] [Page 55739] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-24335] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993--Medical CBRN Defense Consortium Notice is hereby given that, on October 16, 2018, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense Consortium (``MCDC'') has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Allegheny-Singer Research Institute DBA AHN Institute, Pittsburgh, PA; Allotropic Tech, Halethorpe, MD; ASELL LLC, Owings Mills, MD; Clear Scientific LLC, Cambridge, MA; FLIR Detection, Inc., Stillwater, OK; FORGE Life Sciences, LLC, Doylestown, PA; IDBiologics, Inc., Nashville, TN; ImmPORT Therapeutics Inc. DBA Antigen Discovery Inc., Irvine, CA; Polo Custom Products, Topeka, KS; SIGA Technologies, Inc., New York, NY; The Albert Sabin Vaccine Institute, Inc. DBA Sabin Vaccine Institute, Washington, DC; VenatoRx Pharmaceuticals, Inc., Malvern, PA; and Windgap Medical, Inc., Watertown, MA, have been added as parties to this venture. Also, Artificial Cell Technologies, Inc., New Haven, CT; Celdara Medical, LLC, Lebanon, NH; HORIBA Instruments, Inc., Edison, NY; Macromoltek, Austin, TX; Philips Healthcare, Andover, MA; Phosphorex Inc., Hopkinton, MA; PPD Development LP, Wilmington, NC; Sequoia Consulting Group, LLC, Lake Forest, CA; and University of Tennessee, Knoxville, Knoxville, TN, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MCDC intends to file additional written notifications disclosing all changes in membership. On November 13, 2015, MCDC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on January 6, 2016 (81 FR 513). The last notification was filed with the Department on August 3, 2018. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on August 24, 2018 (83 FR 42940). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2018-24335 Filed 11-6-18; 8:45 am] BILLING CODE 4410-11-P
![Federal Register / Vol. 83, No. 216 / Wednesday, November 7, 2018 / Notices 55739
INTERNATIONAL TRADE 1671d(b) and 19 U.S.C. 1673d(b)). It Consulting Group, LLC, Lake Forest,
COMMISSION completed and filed its determinations CA; and University of Tennessee,
in these investigations on October 31, Knoxville, Knoxville, TN, have
[Investigation Nos. 701–TA–590 and 731–
TA–1397 (Final)]
2018. The views of the Commission are withdrawn as parties to this venture.
contained in USITC Publication 4834 No other changes have been made in
Sodium Gluconate, Gluconic Acid, and (October 2018), entitled Sodium either the membership or planned
Derivative Products From China Gluconate, Gluconic Acid, and activity of the group research project.
Derivative Products from China: Membership in this group research
Determinations Investigation Nos. 701–TA–590 and project remains open, and MCDC
On the basis of the record 1 developed 731–TA–1397 (Final). intends to file additional written
in the subject investigations, the United By order of the Commission. notifications disclosing all changes in
States International Trade Commission Issued: November 1, 2018. membership.
(‘‘Commission’’) determines, pursuant Lisa Barton, On November 13, 2015, MCDC filed
to the Tariff Act of 1930 (‘‘the Act’’), its original notification pursuant to
Secretary to the Commission.
that an industry in the United States is Section 6(a) of the Act. The Department
materially injured by reason of imports [FR Doc. 2018–24287 Filed 11–6–18; 8:45 am]
of Justice published a notice in the
of Sodium Gluconate, Gluconic Acid, BILLING CODE 7020–02–P
Federal Register pursuant to Section
and Derivative Products from China, 6(b) of the Act on January 6, 2016 (81
provided for in subheadings 2918.16.10, FR 513).
2918.16.50, and 2932.20.50 of the DEPARTMENT OF JUSTICE The last notification was filed with
Harmonized Tariff Schedule of the the Department on August 3, 2018. A
United States, that have been found by Antitrust Division
notice was published in the Federal
the U.S. Department of Commerce Register pursuant to Section 6(b) of the
(‘‘Commerce’’) to be sold in the United Notice Pursuant to the National
Cooperative Research and Production Act on August 24, 2018 (83 FR 42940).
States at less than fair value (‘‘LTFV’’),
and to be subsidized by the government Act of 1993—Medical CBRN Defense Suzanne Morris,
of China. Consortium Chief, Premerger and Division Statistics Unit,
Antitrust Division.
Background Notice is hereby given that, on
October 16, 2018, pursuant to Section [FR Doc. 2018–24335 Filed 11–6–18; 8:45 am]
The Commission, pursuant to sections
6(a) of the National Cooperative BILLING CODE 4410–11–P
705(b) and 735(b) of the Act (19 U.S.C.
Research and Production Act of 1993,
1671d(b) and 19 U.S.C. 1673d(b)),
15 U.S.C. 4301 et seq. (‘‘the Act’’),
instituted these investigations effective DEPARTMENT OF JUSTICE
Medical CBRN Defense Consortium
November 30, 2017, following receipt of
(‘‘MCDC’’) has filed written notifications Antitrust Division
a petition filed with the Commission
simultaneously with the Attorney
and Commerce by PMP Fermentation
General and the Federal Trade Notice Pursuant to the National
Products (‘‘PMP’’), Inc., Peoria, Illinois.
Commission disclosing changes in its Cooperative Research and Production
The final phase of the investigations
membership. The notifications were Act of 1993—National Spectrum
was scheduled by the Commission
filed for the purpose of extending the Consortium
following notification of preliminary
Act’s provisions limiting the recovery of
determinations by Commerce that Notice is hereby given that, on
antitrust plaintiffs to actual damages
imports of Sodium Gluconate, Gluconic October 29, 2018, pursuant to Section
under specified circumstances.
Acid, and Derivative Products from 6(a) of the National Cooperative
Specifically, Allegheny-Singer Research
China were subsidized within the Research and Production Act of 1993,
Institute DBA AHN Institute, Pittsburgh,
meaning of section 703(b) of the Act (19 15 U.S.C. 4301 et seq. (‘‘the Act’’),
PA; Allotropic Tech, Halethorpe, MD;
U.S.C. 1671b(b)) and sold at LTFV National Spectrum Consortium (‘‘NSC’’)
ASELL LLC, Owings Mills, MD; Clear
within the meaning of 733(b) of the Act has filed written notifications
Scientific LLC, Cambridge, MA; FLIR
(19 U.S.C. 1673b(b)). Notice of the simultaneously with the Attorney
Detection, Inc., Stillwater, OK; FORGE
scheduling of the final phase of the General and the Federal Trade
Life Sciences, LLC, Doylestown, PA;
Commission’s investigations and of a Commission disclosing changes in its
IDBiologics, Inc., Nashville, TN;
public hearing to be held in connection membership. The notifications were
ImmPORT Therapeutics Inc. DBA
therewith was given by posting copies filed for the purpose of extending the
Antigen Discovery Inc., Irvine, CA; Polo
of the notice in the Office of the Act’s provisions limiting the recovery of
Custom Products, Topeka, KS; SIGA
Secretary, U.S. International Trade antitrust plaintiffs to actual damages
Technologies, Inc., New York, NY; The
Commission, Washington, DC, and by under specified circumstances.
Albert Sabin Vaccine Institute, Inc. DBA
publishing the notice in the Federal Specifically, Geon Technologies, LLC,
Sabin Vaccine Institute, Washington,
Register on July 18, 2018 (83 FR 33944). Columbia, MD; Herrick Technology
DC; VenatoRx Pharmaceuticals, Inc.,
The hearing was held in Washington, Laboratories, Inc., Germantown, MD;
Malvern, PA; and Windgap Medical,
DC, on September 18, 2018, and all T2S, LLC, Whiteford, MD; GenXComm,
Inc., Watertown, MA, have been added
persons who requested the opportunity Inc., Austin, TX; Beatty and Company
as parties to this venture.
were permitted to appear in person or Computing, Inc., Rancho Santa Fe, CA;
Also, Artificial Cell Technologies,
amozie on DSK3GDR082PROD with NOTICES1
by counsel. Baylor University, Waco, TX; Applied
The Commission made these Inc., New Haven, CT; Celdara Medical,
LLC, Lebanon, NH; HORIBA Engineering Concepts, Inc., Eldersburg,
determinations pursuant to sections
Instruments, Inc., Edison, NY; MD; and OST, Inc., McLean, VA, have
705(b) and 735(b) of the Act (19 U.S.C.
Macromoltek, Austin, TX; Philips been added as parties to this venture.
1 The record is defined in sec. 207.2(f) of the Healthcare, Andover, MA; Phosphorex Also, Interoptek, Inc., N. Charleston,
Commission’s Rules of Practice and Procedure (19 Inc., Hopkinton, MA; PPD Development SC; Kranze Technology Solutions, Inc.,
CFR 207.2(f)). LP, Wilmington, NC; Sequoia Prospect Heights, IL; and G5 Scientific,
VerDate Sep<11>2014 17:46 Nov 06, 2018 Jkt 247001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\07NON1.SGM 07NON1](https://thefederalregister.org/doc/83_FR_55955/page/1.svg)
Document Created: 2018-11-07 00:05:12
Document Modified: 2018-11-07 00:05:12
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 83 FR 55739 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR